. (GEVA)
$238.60 - (-)
Market Cap: -
As of 09/16/16 12:00 AM EDT. Market closed.
. (GEVA)
$238.60
- (-)
Market Cap: -
As of 09/16/16 12:00 AM EDT. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$238.60
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$238.60
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Quinn Anthony | EVP, CMO, & Head of R&D | Jun 22, 2015 | Option Exercise | $78.87 | 38 | 2,997 | 32,675 | Jun 23, 2015, 10:41 AM |
| Heberlig Chris | SVP, Finance & Business Ops. | Jun 22, 2015 | Option Exercise | $78.87 | 56 | 4,417 | 24,446 | Jun 23, 2015, 10:33 AM |
| Williams Glen | SVP, Technical Operations | Jun 22, 2015 | Option Exercise | $78.87 | 56 | 4,417 | 26,024 | Jun 23, 2015, 10:31 AM |
| Williams Glen | SVP, Technical Operations | Jun 08, 2015 | Option Exercise | $76.30 | 12,916 | 985,472 | 38,884 | Jun 09, 2015, 06:13 PM |
| Williams Glen | SVP, Technical Operations | Jun 08, 2015 | Sale | $214.92 | 12,916 | 2,775,844 | 28,488 | Jun 09, 2015, 06:13 PM |
| Williams Glen | SVP, Technical Operations | May 06, 2015 | Option Exercise | $48.94 | 1,666 | 81,534 | 2,134 | May 08, 2015, 05:07 PM |
| Williams Glen | SVP, Technical Operations | May 06, 2015 | Sale | $205.62 | 1,666 | 342,564 | 1,468 | May 08, 2015, 05:07 PM |
| Quinn Anthony | EVP, CMO & Head of R&D | Apr 27, 2015 | Option Exercise | $1.70 | 10,000 | 17,000 | 15,637 | Apr 29, 2015, 05:28 PM |
| Quinn Anthony | EVP, CMO & Head of R&D | Apr 27, 2015 | Sale | $110.00 | 10,000 | 1,100,000 | 5,637 | Apr 29, 2015, 05:28 PM |
| Quinn Anthony | EVP, CMO & Head of R&D | Apr 21, 2015 | Sale | $108.00 | 10,000 | 1,080,000 | 5,637 | Apr 23, 2015, 07:28 PM |
| Quinn Anthony | EVP, CMO & Head of R&D | Apr 15, 2015 | Option Exercise | $40.74 | 10,000 | 407,400 | 25,637 | Apr 17, 2015, 05:14 PM |
| Quinn Anthony | EVP, CMO & Head of R&D | Apr 15, 2015 | Sale | $105.00 | 10,000 | 1,050,000 | 15,637 | Apr 17, 2015, 05:14 PM |
| Williams Glen | SVP, Technical Operations | Apr 07, 2015 | Option Exercise | $76.88 | 85 | 6,535 | 468 | Apr 09, 2015, 05:21 PM |
| Williams Glen | SVP, Technical Operations | Apr 08, 2015 | Option Exercise | $50.96 | 39,863 | 2,031,380 | 40,331 | Apr 09, 2015, 05:21 PM |
| Williams Glen | SVP, Technical Operations | Apr 07, 2015 | Option Exercise | $40.32 | 2,769 | 111,646 | 3,237 | Apr 09, 2015, 05:21 PM |
| Williams Glen | SVP, Technical Operations | Apr 08, 2015 | Sale | $96.08 | 39,863 | 3,830,037 | 468 | Apr 09, 2015, 05:21 PM |
| Williams Glen | SVP, Technical Operations | Apr 07, 2015 | Sale | $96.04 | 2,769 | 265,935 | 468 | Apr 09, 2015, 05:21 PM |
| Quinn Anthony | EVP, CMO & Head of R&D | Apr 06, 2015 | Option Exercise | $76.88 | 42 | 3,229 | 25,637 | Apr 08, 2015, 06:35 PM |
| Quinn Anthony | EVP, CMO & Head of R&D | Apr 06, 2015 | Option Exercise | $11.69 | 19,503 | 228,069 | 45,140 | Apr 08, 2015, 06:35 PM |
| Quinn Anthony | EVP, CMO & Head of R&D | Apr 06, 2015 | Sale | $93.76 | 29,503 | 2,766,201 | 15,637 | Apr 08, 2015, 06:35 PM |
| Heberlig Chris | SVP, Finance and Business Ops. | Mar 11, 2015 | Option Exercise | $76.88 | 86 | 6,612 | 390 | Mar 13, 2015, 05:49 PM |
| Heberlig Chris | SVP, Finance and Business Ops. | Mar 11, 2015 | Option Exercise | $40.74 | 7,500 | 305,550 | 7,890 | Mar 13, 2015, 05:49 PM |
| Heberlig Chris | SVP, Finance and Business Ops. | Mar 11, 2015 | Sale | $103.17 | 7,500 | 773,740 | 6,990 | Mar 13, 2015, 05:49 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Feb 17, 2015 | Option Exercise | $28.52 | 42,297 | 1,206,485 | 42,297 | Feb 19, 2015, 04:21 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Feb 17, 2015 | Sale | $100.11 | 42,297 | 4,234,403 | 33,308 | Feb 19, 2015, 04:21 PM |
| BAKER FELIX | Director | Jan 07, 2015 | Buy | $94.19 | 1,000,000 | 94,190,002 | 9,184,771 | Jan 09, 2015, 05:29 PM |
| BAKER JULIAN | Director | Jan 07, 2015 | Buy | $94.19 | 1,000,000 | 94,190,002 | 9,184,771 | Jan 09, 2015, 05:28 PM |
| Heberlig Chris | Group Vice President, Finance | Dec 29, 2014 | Option Exercise | $19.16 | 6,100 | 116,870 | 6,404 | Dec 30, 2014, 04:49 PM |
| Heberlig Chris | Group Vice President, Finance | Dec 29, 2014 | Sale | $91.14 | 6,100 | 555,971 | 4,604 | Dec 30, 2014, 04:49 PM |
| Patel Sanj K | President & CEO | Dec 17, 2014 | Option Exercise | $15.28 | 50,000 | 763,972 | 51,031 | Dec 19, 2014, 05:56 PM |
| Patel Sanj K | President & CEO | Dec 17, 2014 | Sale | $88.85 | 50,000 | 4,442,363 | 46,015 | Dec 19, 2014, 05:56 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Oct 30, 2014 | Option Exercise | $9.00 | 22,904 | 206,227 | 22,904 | Oct 30, 2014, 08:21 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Oct 28, 2014 | Option Exercise | $10.22 | 2,500 | 25,550 | 2,500 | Oct 30, 2014, 08:21 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Oct 30, 2014 | Sale | $80.11 | 22,904 | 1,834,839 | 0 | Oct 30, 2014, 08:21 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Oct 28, 2014 | Sale | $80.00 | 2,500 | 200,000 | 1,000 | Oct 30, 2014, 08:21 PM |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Sep 19, 2014 | Option Exercise | $8.73 | 790 | 6,897 | 1,352 | Sep 19, 2014, 05:56 PM |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Sep 19, 2014 | Sale | $65.24 | 790 | 51,540 | 562 | Sep 19, 2014, 05:56 PM |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Sep 17, 2014 | Option Exercise | $8.73 | 4,200 | 36,666 | 4,762 | Sep 18, 2014, 05:21 PM |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Sep 16, 2014 | Option Exercise | $8.73 | 9,379 | 81,879 | 9,941 | Sep 18, 2014, 05:21 PM |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Sep 17, 2014 | Sale | $65.06 | 4,200 | 273,252 | 562 | Sep 18, 2014, 05:21 PM |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Sep 16, 2014 | Sale | $65.01 | 9,379 | 609,729 | 562 | Sep 18, 2014, 05:21 PM |
| Quinn Anthony | EVP, CMO & Head of R&D | Sep 02, 2014 | Option Exercise | $23.00 | 10,000 | 230,000 | 35,595 | Sep 04, 2014, 05:21 PM |
| Quinn Anthony | EVP, CMO & Head of R&D | Sep 02, 2014 | Sale | $70.14 | 10,000 | 701,404 | 26,995 | Sep 04, 2014, 05:21 PM |
| Heberlig Chris | Jun 30, 2014 | Option Exercise | $54.89 | 112 | 6,148 | 304 | Jul 02, 2014, 05:56 PM | |
| Quinn Anthony | EVP, CMO & Head of R&D | Jun 30, 2014 | Option Exercise | $54.89 | 71 | 3,897 | 25,595 | Jul 02, 2014, 05:56 PM |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Jun 30, 2014 | Option Exercise | $54.89 | 103 | 5,654 | 562 | Jul 02, 2014, 05:56 PM |
| Williams Glen | Jun 30, 2014 | Option Exercise | $54.89 | 117 | 6,422 | 383 | Jul 02, 2014, 05:49 PM | |
| Williams Glen | SVP, Technical Operations | Jun 25, 2014 | Option Exercise | $50.17 | 700 | 35,120 | 966 | Jun 26, 2014, 04:21 PM |
| Williams Glen | SVP, Technical Operations | Jun 25, 2014 | Sale | $108.02 | 700 | 75,614 | 266 | Jun 26, 2014, 04:21 PM |
| Quart Barry D | Director | Jun 20, 2014 | Option Exercise | $25.00 | 1,375 | 34,375 | 1,375 | Jun 24, 2014, 05:07 PM |
| Quart Barry D | Director | Jun 20, 2014 | Sale | $100.00 | 1,375 | 137,500 | 0 | Jun 24, 2014, 05:07 PM |
| BAKER FELIX | Director | Jun 20, 2014 | Option Exercise | $60.45 | 29,750 | 1,798,388 | 8,184,771 | Jun 24, 2014, 04:12 PM |
| Quart Barry D | Director | Jun 17, 2014 | Option Exercise | $23.95 | 1,000 | 23,950 | 1,000 | Jun 19, 2014, 05:28 PM |
| Quart Barry D | Director | Jun 17, 2014 | Sale | $90.00 | 1,000 | 90,000 | 0 | Jun 19, 2014, 05:28 PM |
| Quart Barry D | Director | Jun 12, 2014 | Option Exercise | $23.00 | 1,000 | 23,000 | 1,000 | Jun 16, 2014, 06:56 PM |
| Quart Barry D | Director | Jun 12, 2014 | Sale | $83.31 | 1,000 | 83,310 | 0 | Jun 16, 2014, 06:56 PM |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Jun 11, 2014 | Option Exercise | $7.66 | 21,597 | 165,513 | 22,056 | Jun 12, 2014, 05:07 PM |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Jun 11, 2014 | Sale | $80.00 | 21,597 | 1,727,760 | 459 | Jun 12, 2014, 05:07 PM |
| BOESS CARSTEN | May 16, 2014 | Option Exercise | $1.70 | 9,927 | 16,876 | 9,927 | May 20, 2014, 04:42 PM | |
| BOESS CARSTEN | May 16, 2014 | Sale | $81.94 | 9,927 | 813,402 | 1,791 | May 20, 2014, 04:42 PM | |
| BAKER FELIX | Director | Apr 23, 2014 | Option Exercise | $65.10 | 56,000 | 3,645,600 | 8,180,521 | Apr 25, 2014, 08:04 PM |
| Quinn Anthony | EVP, CMO & Head of R&D | Apr 01, 2014 | Option Exercise | $0.95 | 10,000 | 9,500 | 25,524 | Apr 03, 2014, 09:56 PM |
| Quinn Anthony | EVP, CMO & Head of R&D | Apr 01, 2014 | Option Exercise | $11.97 | 20,000 | 239,500 | 35,524 | Apr 03, 2014, 05:56 PM |
| Quinn Anthony | EVP, CMO & Head of R&D | Apr 01, 2014 | Sale | $83.53 | 20,000 | 1,670,691 | 24,849 | Apr 03, 2014, 05:56 PM |
| Heberlig Chris | Group Vice President, Finance | Mar 12, 2014 | Option Exercise | $15.51 | 7,670 | 118,924 | 7,862 | Mar 14, 2014, 04:07 PM |
| Heberlig Chris | Group Vice President, Finance | Mar 12, 2014 | Sale | $98.56 | 7,670 | 755,992 | 7,162 | Mar 14, 2014, 04:07 PM |
| BAKER JULIAN | Director | Mar 06, 2014 | Buy | $105.75 | 375,000 | 39,656,250 | 8,172,521 | Mar 07, 2014, 05:54 PM |
| BAKER FELIX | Director | Mar 06, 2014 | Buy | $105.75 | 375,000 | 39,656,250 | 8,172,521 | Mar 07, 2014, 05:53 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Feb 18, 2014 | Option Exercise | $1.70 | 9,927 | 16,876 | 9,927 | Feb 20, 2014, 04:14 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Feb 18, 2014 | Sale | $101.98 | 9,927 | 1,012,369 | 8,927 | Feb 20, 2014, 04:14 PM |
| Patel Sanj K | President & CEO | Jan 28, 2014 | Option Exercise | $2.49 | 51,329 | 127,874 | 52,360 | Jan 30, 2014, 05:42 PM |
| Patel Sanj K | President & CEO | Jan 29, 2014 | Option Exercise | $3.52 | 50,971 | 179,418 | 52,002 | Jan 30, 2014, 05:42 PM |
| Patel Sanj K | President & CEO | Jan 29, 2014 | Sale | $87.97 | 50,971 | 4,483,953 | 27,185 | Jan 30, 2014, 05:42 PM |
| Patel Sanj K | President & CEO | Jan 28, 2014 | Sale | $88.27 | 51,329 | 4,531,045 | 42,854 | Jan 30, 2014, 05:42 PM |
| Quinn Anthony | EVP, CMO & Head of R&D | Dec 31, 2013 | Option Exercise | $36.30 | 192 | 6,970 | 15,524 | Jan 02, 2014, 07:14 PM |
| Williams Glen | SVP, Technical Operations | Dec 31, 2013 | Option Exercise | $36.30 | 132 | 4,792 | 266 | Jan 02, 2014, 07:14 PM |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Dec 31, 2013 | Option Exercise | $36.30 | 192 | 6,970 | 459 | Jan 02, 2014, 07:07 PM |
| Heberlig Chris | Group Vice President, Finance | Dec 31, 2013 | Option Exercise | $36.30 | 192 | 6,970 | 192 | Jan 02, 2014, 07:07 PM |
| Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | Dec 02, 2013 | Option Exercise | $8.73 | 7,000 | 61,110 | 7,267 | Dec 04, 2013, 05:07 PM |
| Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | Dec 03, 2013 | Sale | $60.52 | 7,000 | 423,649 | 680 | Dec 04, 2013, 05:07 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Nov 18, 2013 | Option Exercise | $1.70 | 9,927 | 16,876 | 9,927 | Nov 20, 2013, 04:56 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Nov 18, 2013 | Sale | $55.09 | 9,927 | 546,857 | 6,066 | Nov 20, 2013, 04:56 PM |
| Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | Nov 01, 2013 | Option Exercise | $8.73 | 7,000 | 61,110 | 7,267 | Nov 04, 2013, 05:35 PM |
| Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | Nov 01, 2013 | Sale | $49.96 | 7,000 | 349,753 | 3,572 | Nov 04, 2013, 05:35 PM |
| Goldberg Mark Alan | Oct 01, 2013 | Option Exercise | $8.73 | 7,000 | 61,110 | 7,267 | Oct 03, 2013, 04:07 PM | |
| Goldberg Mark Alan | Oct 01, 2013 | Sale | $64.31 | 7,000 | 450,203 | 4,037 | Oct 03, 2013, 04:07 PM | |
| BAKER FELIX | Director | Sep 25, 2013 | Buy | $56.63 | 1,050,000 | 59,461,501 | 7,806,552 | Sep 27, 2013, 04:08 PM |
| BAKER JULIAN | Director | Sep 25, 2013 | Buy | $56.63 | 1,050,000 | 59,461,501 | 7,806,552 | Sep 27, 2013, 04:08 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Aug 21, 2013 | Option Exercise | $23.00 | 6,681 | 153,663 | 6,681 | Aug 22, 2013, 05:28 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Aug 20, 2013 | Option Exercise | $7.63 | 7,800 | 59,545 | 7,800 | Aug 22, 2013, 05:28 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Aug 20, 2013 | Sale | $47.04 | 7,800 | 366,912 | 0 | Aug 22, 2013, 05:28 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Aug 21, 2013 | Sale | $47.19 | 6,681 | 315,276 | 0 | Aug 22, 2013, 05:28 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Aug 16, 2013 | Option Exercise | $1.70 | 4,300 | 7,310 | 4,300 | Aug 20, 2013, 05:35 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Aug 16, 2013 | Sale | $47.47 | 4,300 | 204,121 | 0 | Aug 20, 2013, 05:35 PM |
| Patel Sanj K | President & CEO | Jul 26, 2013 | Option Exercise | $2.93 | 52,190 | 152,984 | 70,425 | Jul 29, 2013, 06:35 PM |
| Patel Sanj K | President & CEO | Jul 25, 2013 | Option Exercise | $1.42 | 31,915 | 45,319 | 32,946 | Jul 29, 2013, 06:35 PM |
| Patel Sanj K | President & CEO | Jul 29, 2013 | Option Exercise | $3.52 | 15,895 | 55,950 | 16,926 | Jul 29, 2013, 06:35 PM |
| Patel Sanj K | President & CEO | Jul 26, 2013 | Sale | $48.01 | 69,394 | 3,331,548 | 18,235 | Jul 29, 2013, 06:35 PM |
| Patel Sanj K | President & CEO | Jul 25, 2013 | Sale | $48.73 | 14,711 | 716,867 | 18,235 | Jul 29, 2013, 06:35 PM |
| Patel Sanj K | President & CEO | Jul 29, 2013 | Sale | $47.39 | 15,895 | 753,264 | 1,031 | Jul 29, 2013, 06:35 PM |
| Heberlig Chris | Vice President, Finance | Jul 15, 2013 | Option Exercise | $1.07 | 2,524 | 2,698 | 2,524 | Jul 17, 2013, 04:21 PM |
| Heberlig Chris | Vice President, Finance | Jul 16, 2013 | Sale | $48.26 | 2,029 | 97,920 | 0 | Jul 17, 2013, 04:21 PM |
| Heberlig Chris | Vice President, Finance | Jul 15, 2013 | Sale | $49.15 | 495 | 24,329 | 2,029 | Jul 17, 2013, 04:21 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Jul 11, 2013 | Option Exercise | $1.70 | 13,237 | 22,503 | 13,237 | Jul 15, 2013, 04:35 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Jul 11, 2013 | Sale | $47.06 | 13,237 | 622,933 | 0 | Jul 15, 2013, 04:35 PM |
| Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | Jun 28, 2013 | Option Exercise | $35.68 | 267 | 9,527 | 267 | Jul 01, 2013, 05:07 PM |
| Williams Glen | Jun 28, 2013 | Option Exercise | $35.68 | 134 | 4,781 | 134 | Jul 01, 2013, 05:07 PM | |
| Quinn Anthony | Jun 28, 2013 | Option Exercise | $35.68 | 297 | 10,597 | 15,332 | Jul 01, 2013, 05:07 PM | |
| Patel Sanj K | President & CEO | Jun 11, 2013 | Option Exercise | $0.95 | 29,648 | 28,166 | 30,679 | Jun 13, 2013, 05:28 PM |
| Patel Sanj K | President & CEO | Jun 12, 2013 | Option Exercise | $1.22 | 40,352 | 49,383 | 41,383 | Jun 13, 2013, 05:28 PM |
| Patel Sanj K | President & CEO | Jun 12, 2013 | Sale | $40.48 | 40,352 | 1,633,449 | 1,031 | Jun 13, 2013, 05:28 PM |
| Patel Sanj K | President & CEO | Jun 11, 2013 | Sale | $40.89 | 29,648 | 1,212,307 | 1,031 | Jun 13, 2013, 05:28 PM |
| Patel Sanj K | President & CEO | Apr 08, 2013 | Option Exercise | $0.95 | 21,695 | 20,610 | 22,726 | Apr 09, 2013, 04:21 PM |
| Patel Sanj K | President & CEO | Apr 05, 2013 | Option Exercise | $0.95 | 9,910 | 9,414 | 10,941 | Apr 09, 2013, 04:21 PM |
| Patel Sanj K | President & CEO | Apr 08, 2013 | Sale | $49.49 | 21,695 | 1,073,686 | 1,031 | Apr 09, 2013, 04:21 PM |
| Patel Sanj K | President & CEO | Apr 05, 2013 | Sale | $50.11 | 9,910 | 496,590 | 1,031 | Apr 09, 2013, 04:21 PM |
| Patel Sanj K | President & CEO | Apr 03, 2013 | Option Exercise | $0.95 | 16,464 | 15,641 | 17,495 | Apr 05, 2013, 02:21 PM |
| Patel Sanj K | President & CEO | Apr 04, 2013 | Option Exercise | $0.95 | 21,931 | 20,834 | 22,962 | Apr 05, 2013, 02:21 PM |
| Patel Sanj K | President & CEO | Apr 03, 2013 | Sale | $51.76 | 16,464 | 852,227 | 7,289 | Apr 05, 2013, 02:21 PM |
| Patel Sanj K | President & CEO | Apr 04, 2013 | Sale | $50.26 | 21,931 | 1,102,315 | 4,382 | Apr 05, 2013, 02:21 PM |
| Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | Apr 01, 2013 | Option Exercise | $0.95 | 4,416 | 4,195 | 4,416 | Apr 03, 2013, 10:21 AM |
| Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | Apr 01, 2013 | Sale | $54.31 | 4,416 | 239,831 | 619 | Apr 03, 2013, 10:21 AM |
| Goldberg Mark Alan | SVP, Product Development | Mar 01, 2013 | Option Exercise | $0.95 | 4,417 | 4,196 | 4,417 | Mar 06, 2013, 06:00 AM |
| Goldberg Mark Alan | SVP, Product Development | Mar 01, 2013 | Sale | $50.76 | 4,417 | 224,217 | 1,713 | Mar 06, 2013, 06:00 AM |
| Patel Sanj K | President & CEO | Feb 21, 2013 | Option Exercise | $0.95 | 45,392 | 43,122 | 46,423 | Feb 22, 2013, 05:05 PM |
| Patel Sanj K | President & CEO | Feb 20, 2013 | Option Exercise | $0.95 | 24,608 | 23,378 | 25,639 | Feb 22, 2013, 05:05 PM |
| Patel Sanj K | President & CEO | Feb 21, 2013 | Sale | $49.02 | 45,392 | 2,225,116 | 1,031 | Feb 22, 2013, 05:05 PM |
| Patel Sanj K | President & CEO | Feb 20, 2013 | Sale | $49.52 | 24,608 | 1,218,505 | 6,985 | Feb 22, 2013, 05:05 PM |
| Goldberg Mark Alan | SVP, Product Development | Feb 01, 2013 | Option Exercise | $0.95 | 4,417 | 4,196 | 4,417 | Feb 05, 2013, 05:35 PM |
| Goldberg Mark Alan | SVP, Product Development | Feb 01, 2013 | Sale | $47.75 | 4,417 | 210,892 | 2,660 | Feb 05, 2013, 05:35 PM |
| Quinn Anthony | SVP, Chief Medical Officer | Jan 18, 2013 | Option Exercise | $0.95 | 9,447 | 8,975 | 24,482 | Jan 23, 2013, 05:05 PM |
| Quinn Anthony | SVP, Chief Medical Officer | Jan 18, 2013 | Sale | $50.08 | 9,447 | 473,106 | 15,035 | Jan 23, 2013, 05:05 PM |
| Quinn Anthony | SVP, Chief Medical Officer | Jan 17, 2013 | Option Exercise | $0.95 | 200 | 190 | 15,235 | Jan 18, 2013, 05:00 PM |
| Quinn Anthony | SVP, Chief Medical Officer | Jan 16, 2013 | Option Exercise | $0.95 | 353 | 335 | 20,388 | Jan 18, 2013, 05:00 PM |
| Quinn Anthony | SVP, Chief Medical Officer | Jan 17, 2013 | Sale | $50.00 | 200 | 10,000 | 15,035 | Jan 18, 2013, 05:00 PM |
| Quinn Anthony | SVP, Chief Medical Officer | Jan 16, 2013 | Sale | $50.07 | 5,353 | 268,025 | 15,035 | Jan 18, 2013, 05:00 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Jan 16, 2013 | Option Exercise | $1.70 | 9,927 | 16,876 | 9,927 | Jan 18, 2013, 04:50 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Jan 16, 2013 | Sale | $49.12 | 9,927 | 487,614 | 0 | Jan 18, 2013, 04:50 PM |
| TISCH THOMAS J | Director | Jan 09, 2013 | Buy | $47.53 | 21,039 | 999,984 | 373,560 | Jan 15, 2013, 05:48 PM |
| BAKER FELIX | Director | Jan 04, 2013 | Buy | $47.53 | 859,720 | 40,862,491 | 6,782,215 | Jan 08, 2013, 05:41 PM |
| BAKER JULIAN | Director | Jan 04, 2013 | Buy | $47.53 | 859,720 | 40,862,491 | 6,782,215 | Jan 08, 2013, 05:40 PM |
| Goldberg Mark Alan | SVP, Product Development | Jan 02, 2013 | Option Exercise | $0.95 | 4,417 | 4,196 | 4,417 | Jan 04, 2013, 04:30 PM |
| Goldberg Mark Alan | SVP, Product Development | Jan 02, 2013 | Sale | $47.52 | 4,417 | 209,896 | 0 | Jan 04, 2013, 04:30 PM |
| Heberlig Chris | Vice President, Finance | Dec 19, 2012 | Option Exercise | $0.95 | 4,000 | 3,800 | 4,000 | Dec 21, 2012, 03:45 PM |
| Heberlig Chris | Vice President, Finance | Dec 19, 2012 | Sale | $45.93 | 4,000 | 183,705 | 1,605 | Dec 21, 2012, 03:45 PM |
| Patel Sanj K | President & CEO | Dec 13, 2012 | Option Exercise | $0.95 | 14,400 | 13,680 | 15,431 | Dec 17, 2012, 07:15 PM |
| Patel Sanj K | President & CEO | Dec 17, 2012 | Option Exercise | $0.95 | 32,319 | 30,703 | 33,350 | Dec 17, 2012, 07:15 PM |
| Patel Sanj K | President & CEO | Dec 14, 2012 | Option Exercise | $0.95 | 13,281 | 12,617 | 14,312 | Dec 17, 2012, 07:15 PM |
| Patel Sanj K | President & CEO | Dec 17, 2012 | Sale | $46.83 | 32,319 | 1,513,338 | 26,346 | Dec 17, 2012, 07:15 PM |
| Patel Sanj K | President & CEO | Dec 14, 2012 | Sale | $45.30 | 13,281 | 601,629 | 1,031 | Dec 17, 2012, 07:15 PM |
| Patel Sanj K | President & CEO | Dec 13, 2012 | Sale | $45.66 | 14,400 | 657,470 | 7,032 | Dec 17, 2012, 07:15 PM |
| Patel Sanj K | President & CEO | Dec 05, 2012 | Option Exercise | $0.95 | 12,000 | 11,400 | 13,031 | Dec 06, 2012, 05:05 PM |
| Patel Sanj K | President & CEO | Dec 04, 2012 | Option Exercise | $0.95 | 23,000 | 21,850 | 24,031 | Dec 06, 2012, 05:05 PM |
| Patel Sanj K | President & CEO | Dec 05, 2012 | Sale | $48.10 | 12,000 | 577,255 | 1,031 | Dec 06, 2012, 05:05 PM |
| Patel Sanj K | President & CEO | Dec 04, 2012 | Sale | $49.34 | 23,000 | 1,134,850 | 1,031 | Dec 06, 2012, 05:05 PM |
| Patel Sanj K | President & CEO | Dec 03, 2012 | Option Exercise | $0.95 | 30,000 | 28,500 | 31,031 | Dec 04, 2012, 05:20 PM |
| Patel Sanj K | President & CEO | Nov 30, 2012 | Option Exercise | $0.95 | 5,000 | 4,750 | 6,031 | Dec 04, 2012, 05:20 PM |
| Patel Sanj K | President & CEO | Nov 30, 2012 | Sale | $48.87 | 5,000 | 244,326 | 1,031 | Dec 04, 2012, 05:20 PM |
| Patel Sanj K | President & CEO | Dec 03, 2012 | Sale | $49.42 | 30,000 | 1,482,492 | 1,031 | Dec 04, 2012, 05:20 PM |
| Heberlig Chris | Vice President, Finance | Oct 17, 2012 | Option Exercise | $1.33 | 4,000 | 5,300 | 4,000 | Oct 19, 2012, 05:10 PM |
| Heberlig Chris | Vice President, Finance | Oct 17, 2012 | Sale | $49.65 | 4,000 | 198,620 | 2,000 | Oct 19, 2012, 05:10 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Oct 16, 2012 | Option Exercise | $1.70 | 9,927 | 16,876 | 9,927 | Oct 18, 2012, 05:40 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Oct 16, 2012 | Sale | $50.13 | 9,927 | 497,650 | 2,800 | Oct 18, 2012, 05:40 PM |
| Heberlig Chris | Vice President, Finance | Sep 04, 2012 | Option Exercise | $0.95 | 1,000 | 950 | 1,000 | Sep 06, 2012, 05:00 PM |
| Heberlig Chris | Vice President, Finance | Sep 04, 2012 | Sale | $49.10 | 1,000 | 49,100 | 300 | Sep 06, 2012, 05:00 PM |
| Patel Sanj K | President & CEO | Sep 04, 2012 | Option Exercise | $0.95 | 54,813 | 52,072 | 55,844 | Sep 05, 2012, 05:30 PM |
| Patel Sanj K | President & CEO | Aug 31, 2012 | Option Exercise | $0.95 | 15,187 | 14,428 | 16,218 | Sep 05, 2012, 05:30 PM |
| Patel Sanj K | President & CEO | Sep 04, 2012 | Sale | $49.36 | 54,813 | 2,705,372 | 1,031 | Sep 05, 2012, 05:30 PM |
| Patel Sanj K | President & CEO | Aug 31, 2012 | Sale | $49.88 | 15,187 | 757,518 | 1,031 | Sep 05, 2012, 05:30 PM |
| Quinn Anthony | SVP, Chief Medical Officer | Jul 27, 2012 | Option Exercise | $0.95 | 6,400 | 6,080 | 26,435 | Jul 30, 2012, 04:50 PM |
| Quinn Anthony | SVP, Chief Medical Officer | Jul 26, 2012 | Option Exercise | $0.95 | 1,100 | 1,045 | 21,135 | Jul 30, 2012, 04:50 PM |
| Quinn Anthony | SVP, Chief Medical Officer | Jul 26, 2012 | Sale | $50.00 | 1,100 | 55,000 | 20,035 | Jul 30, 2012, 04:50 PM |
| Quinn Anthony | SVP, Chief Medical Officer | Jul 27, 2012 | Sale | $50.23 | 6,400 | 321,501 | 20,035 | Jul 30, 2012, 04:50 PM |
| Quinn Anthony | SVP, Chief Medical Officer | Jul 19, 2012 | Option Exercise | $0.95 | 1,900 | 1,805 | 21,935 | Jul 23, 2012, 05:10 PM |
| Quinn Anthony | SVP, Chief Medical Officer | Jul 20, 2012 | Option Exercise | $0.95 | 600 | 570 | 20,635 | Jul 23, 2012, 05:10 PM |
| Quinn Anthony | SVP, Chief Medical Officer | Jul 20, 2012 | Sale | $50.00 | 600 | 30,000 | 20,035 | Jul 23, 2012, 05:10 PM |
| Quinn Anthony | SVP, Chief Medical Officer | Jul 19, 2012 | Sale | $50.00 | 1,900 | 95,000 | 20,035 | Jul 23, 2012, 05:10 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Jul 18, 2012 | Option Exercise | $1.70 | 6,618 | 11,251 | 6,618 | Jul 20, 2012, 05:45 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | Jul 18, 2012 | Sale | $48.82 | 6,618 | 323,091 | 0 | Jul 20, 2012, 05:45 PM |
| BAKER JULIAN | Director | Jul 13, 2012 | Buy | $41.20 | 886,000 | 36,503,201 | 5,942,594 | Jul 13, 2012, 06:59 PM |
| BAKER FELIX | Director | Jul 13, 2012 | Buy | $41.20 | 886,000 | 36,503,201 | 5,942,594 | Jul 13, 2012, 06:47 PM |
| TISCH THOMAS J | Director | Jul 12, 2012 | Buy | $41.20 | 36,500 | 1,503,800 | 378,435 | Jul 13, 2012, 04:19 PM |
| TISCH THOMAS J | Director | Jul 12, 2012 | Buy | $41.20 | 36,500 | 1,503,800 | 352,521 | Jul 13, 2012, 04:19 PM |
| TISCH DANIEL R | 10% Owner | Jul 12, 2012 | Sale | $46.75 | 29,200 | 1,365,100 | 186,357 | Jul 13, 2012, 02:32 PM |
| TISCH DANIEL R | 10% Owner | Jul 11, 2012 | Sale | $45.72 | 10,000 | 457,250 | 215,557 | Jul 12, 2012, 06:55 PM |
| TISCH DANIEL R | 10% Owner | Jul 10, 2012 | Sale | $45.22 | 10,000 | 452,250 | 225,557 | Jul 11, 2012, 05:04 PM |
| AKKARAJU SRINIVAS | Former Director | Jun 27, 2012 | Sale | $39.70 | 313,451 | 12,444,005 | 1,026,832 | Jun 28, 2012, 06:01 PM |
| AKKARAJU SRINIVAS | Former Director | Jun 26, 2012 | Sale | $40.16 | 28,827 | 1,157,661 | 1,340,283 | Jun 28, 2012, 06:01 PM |
| Quinn Anthony | SVP, Chief Medical Officer | Jun 25, 2012 | Sale | $40.65 | 26,000 | 1,056,874 | 20,035 | Jun 27, 2012, 05:25 PM |
| Patel Sanj K | President & CEO | Jun 04, 2012 | Option Exercise | $0.95 | 20,866 | 19,823 | 21,897 | Jun 05, 2012, 05:10 PM |
| Patel Sanj K | President & CEO | Jun 01, 2012 | Option Exercise | $0.95 | 29,134 | 27,677 | 30,165 | Jun 05, 2012, 05:10 PM |
| Patel Sanj K | President & CEO | Jun 04, 2012 | Sale | $34.69 | 20,866 | 723,785 | 1,031 | Jun 05, 2012, 05:10 PM |
| Patel Sanj K | President & CEO | Jun 01, 2012 | Sale | $35.78 | 29,134 | 1,042,533 | 10,265 | Jun 05, 2012, 05:10 PM |
| Heberlig Chris | Vice President, Finance | Jun 01, 2012 | Option Exercise | $0.95 | 1,000 | 950 | 1,000 | Jun 05, 2012, 05:10 PM |
| Heberlig Chris | Vice President, Finance | Jun 01, 2012 | Sale | $35.73 | 1,000 | 35,733 | 200 | Jun 05, 2012, 05:10 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | May 16, 2012 | Option Exercise | $1.70 | 39,709 | 67,505 | 39,709 | May 18, 2012, 04:45 PM |
| BOESS CARSTEN | SVP, Chief Financial Officer | May 16, 2012 | Sale | $38.35 | 39,709 | 1,522,933 | 11,572 | May 18, 2012, 04:45 PM |
| TISCH DANIEL R | 10% Owner | Apr 23, 2012 | Sale | $40.10 | 3,000 | 120,300 | 44,750 | Apr 23, 2012, 04:04 PM |
| TISCH DANIEL R | 10% Owner | Apr 20, 2012 | Sale | $39.66 | 10,000 | 396,600 | 47,750 | Apr 23, 2012, 04:04 PM |
| Patel Sanj K | Mar 23, 2012 | Option Exercise | $0.95 | 50,000 | 47,500 | 51,031 | Mar 27, 2012, 05:30 PM | |
| Patel Sanj K | Mar 23, 2012 | Sale | $33.53 | 50,000 | 1,676,410 | 1,031 | Mar 27, 2012, 05:30 PM | |
| AKKARAJU SRINIVAS | Director | Mar 19, 2012 | Sale | $32.55 | 342,278 | 11,141,149 | 1,369,110 | Mar 21, 2012, 06:10 PM |
| TISCH DANIEL R | 10% Owner | Feb 29, 2012 | Sale | $39.19 | 1,512 | 59,255 | 57,750 | Mar 09, 2012, 08:38 AM |
| TISCH DANIEL R | 10% Owner | Feb 29, 2012 | Sale | $39.19 | 3,488 | 136,695 | 167,912 | Mar 09, 2012, 08:38 AM |
| TISCH DANIEL R | 10% Owner | Feb 22, 2012 | Sale | $38.90 | 2,118 | 82,390 | 171,400 | Mar 09, 2012, 08:38 AM |
| TISCH DANIEL R | 10% Owner | Feb 06, 2012 | Sale | $35.62 | 5,716 | 203,604 | 298,285 | Mar 09, 2012, 08:36 AM |
| TISCH DANIEL R | 10% Owner | Feb 17, 2012 | Sale | $38.50 | 9,190 | 353,815 | 174,460 | Mar 09, 2012, 08:36 AM |
| TISCH DANIEL R | 10% Owner | Feb 02, 2012 | Sale | $35.50 | 100 | 3,550 | 304,001 | Mar 09, 2012, 08:36 AM |
| TISCH DANIEL R | 10% Owner | Feb 16, 2012 | Sale | $38.01 | 15,750 | 598,657 | 183,650 | Mar 09, 2012, 08:36 AM |
| TISCH DANIEL R | 10% Owner | Feb 01, 2012 | Sale | $35.50 | 9,975 | 354,113 | 304,101 | Mar 09, 2012, 08:36 AM |
| TISCH DANIEL R | 10% Owner | Feb 15, 2012 | Sale | $37.34 | 24,481 | 914,121 | 199,400 | Mar 09, 2012, 08:36 AM |
| TISCH DANIEL R | 10% Owner | Feb 13, 2012 | Sale | $36.20 | 61,262 | 2,217,684 | 235,557 | Mar 09, 2012, 08:36 AM |
| TISCH DANIEL R | 10% Owner | Feb 10, 2012 | Sale | $35.70 | 582 | 20,777 | 296,819 | Mar 09, 2012, 08:36 AM |
| TISCH DANIEL R | 10% Owner | Feb 07, 2012 | Sale | $35.50 | 884 | 31,382 | 297,401 | Mar 09, 2012, 08:36 AM |
| TISCH DANIEL R | 10% Owner | Feb 21, 2012 | Sale | $38.90 | 942 | 36,644 | 173,518 | Mar 09, 2012, 08:36 AM |
| Heberlig Chris | Vice President, Finance | Feb 27, 2012 | Option Exercise | $0.95 | 4,500 | 4,275 | 4,500 | Feb 29, 2012, 09:27 AM |
| Heberlig Chris | Vice President, Finance | Feb 27, 2012 | Sale | $36.88 | 4,500 | 165,960 | 0 | Feb 29, 2012, 09:27 AM |
| TISCH THOMAS J | 10% Owner | Jan 10, 2012 | Buy | $25.18 | 120,000 | 3,021,600 | 341,935 | Jan 17, 2012, 03:44 PM |
| TISCH THOMAS J | 10% Owner | Jan 10, 2012 | Buy | $25.18 | 1,200,000 | 30,216,000 | 341,935 | Jan 11, 2012, 10:45 AM |
| Baker Brothers Life Sciences Capital (GP), LLC | Director | Jan 05, 2012 | Option Exercise | $25.18 | 1,077,225 | 27,124,526 | 5,077,676 | Jan 09, 2012, 07:01 PM |
| 14159 capital (GP), LLC | Director | Jan 05, 2012 | Option Exercise | $25.18 | 29,089 | 732,461 | 135,739 | Jan 09, 2012, 07:00 PM |
| Baker Biotech Capital (GP), LLC | Director | Jan 05, 2012 | Option Exercise | $25.18 | 187,576 | 4,723,164 | 1,736,065 | Jan 09, 2012, 07:00 PM |
| Malley Thomas | Director | Dec 12, 2011 | Option Exercise | $1.58 | 13,200 | 20,887 | 46,901 | Dec 13, 2011, 05:42 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Aug 19, 2011 | Sale | $2.01 | 6,600 | 13,266 | 2,333,400 | Aug 24, 2011, 10:21 AM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Aug 18, 2011 | Sale | $2.11 | 1,500 | 3,165 | 2,340,000 | Aug 24, 2011, 10:21 AM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Aug 04, 2011 | Buy | $2.18 | 10,000 | 21,800 | 2,341,500 | Aug 10, 2011, 03:16 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Aug 03, 2011 | Buy | $2.22 | 70,000 | 155,100 | 2,331,500 | Aug 05, 2011, 11:36 AM |
| Baker Brothers Life Sciences Capital (GP), LLC | Director | Sep 28, 2010 | Buy | $2.45 | 13,916 | 34,100 | 1,242,773 | Sep 30, 2010, 05:10 PM |
| 14159 capital (GP), LLC | Director | Sep 28, 2010 | Buy | $2.45 | 384 | 941 | 384 | Sep 30, 2010, 04:57 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Quinn Anthony | EVP, CMO, & Head of R&D | 06/22/2015 | 2,997 |
| Heberlig Chris | SVP, Finance & Business Ops. | 06/22/2015 | 4,417 |
| Williams Glen | SVP, Technical Operations | 06/22/2015 | 4,417 |
| Williams Glen | SVP, Technical Operations | 06/08/2015 | 985,472 |
| Williams Glen | SVP, Technical Operations | 06/08/2015 | 2,775,844 |
| Williams Glen | SVP, Technical Operations | 05/06/2015 | 81,534 |
| Williams Glen | SVP, Technical Operations | 05/06/2015 | 342,564 |
| Quinn Anthony | EVP, CMO & Head of R&D | 04/27/2015 | 17,000 |
| Quinn Anthony | EVP, CMO & Head of R&D | 04/27/2015 | 1,100,000 |
| Quinn Anthony | EVP, CMO & Head of R&D | 04/21/2015 | 1,080,000 |
| Quinn Anthony | EVP, CMO & Head of R&D | 04/15/2015 | 407,400 |
| Quinn Anthony | EVP, CMO & Head of R&D | 04/15/2015 | 1,050,000 |
| Williams Glen | SVP, Technical Operations | 04/07/2015 | 6,535 |
| Williams Glen | SVP, Technical Operations | 04/08/2015 | 2,031,380 |
| Williams Glen | SVP, Technical Operations | 04/07/2015 | 111,646 |
| Williams Glen | SVP, Technical Operations | 04/08/2015 | 3,830,037 |
| Williams Glen | SVP, Technical Operations | 04/07/2015 | 265,935 |
| Quinn Anthony | EVP, CMO & Head of R&D | 04/06/2015 | 3,229 |
| Quinn Anthony | EVP, CMO & Head of R&D | 04/06/2015 | 228,069 |
| Quinn Anthony | EVP, CMO & Head of R&D | 04/06/2015 | 2,766,201 |
| Heberlig Chris | SVP, Finance and Business Ops. | 03/11/2015 | 6,612 |
| Heberlig Chris | SVP, Finance and Business Ops. | 03/11/2015 | 305,550 |
| Heberlig Chris | SVP, Finance and Business Ops. | 03/11/2015 | 773,740 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 02/17/2015 | 1,206,485 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 02/17/2015 | 4,234,403 |
| BAKER FELIX | Director | 01/07/2015 | 94,190,002 |
| BAKER JULIAN | Director | 01/07/2015 | 94,190,002 |
| Heberlig Chris | Group Vice President, Finance | 12/29/2014 | 116,870 |
| Heberlig Chris | Group Vice President, Finance | 12/29/2014 | 555,971 |
| Patel Sanj K | President & CEO | 12/17/2014 | 763,972 |
| Patel Sanj K | President & CEO | 12/17/2014 | 4,442,363 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 10/30/2014 | 206,227 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 10/28/2014 | 25,550 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 10/30/2014 | 1,834,839 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 10/28/2014 | 200,000 |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | 09/19/2014 | 6,897 |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | 09/19/2014 | 51,540 |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | 09/17/2014 | 36,666 |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | 09/16/2014 | 81,879 |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | 09/17/2014 | 273,252 |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | 09/16/2014 | 609,729 |
| Quinn Anthony | EVP, CMO & Head of R&D | 09/02/2014 | 230,000 |
| Quinn Anthony | EVP, CMO & Head of R&D | 09/02/2014 | 701,404 |
| Heberlig Chris | 06/30/2014 | 6,148 | |
| Quinn Anthony | EVP, CMO & Head of R&D | 06/30/2014 | 3,897 |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | 06/30/2014 | 5,654 |
| Williams Glen | 06/30/2014 | 6,422 | |
| Williams Glen | SVP, Technical Operations | 06/25/2014 | 35,120 |
| Williams Glen | SVP, Technical Operations | 06/25/2014 | 75,614 |
| Quart Barry D | Director | 06/20/2014 | 34,375 |
| Quart Barry D | Director | 06/20/2014 | 137,500 |
| BAKER FELIX | Director | 06/20/2014 | 1,798,388 |
| Quart Barry D | Director | 06/17/2014 | 23,950 |
| Quart Barry D | Director | 06/17/2014 | 90,000 |
| Quart Barry D | Director | 06/12/2014 | 23,000 |
| Quart Barry D | Director | 06/12/2014 | 83,310 |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | 06/11/2014 | 165,513 |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | 06/11/2014 | 1,727,760 |
| BOESS CARSTEN | 05/16/2014 | 16,876 | |
| BOESS CARSTEN | 05/16/2014 | 813,402 | |
| BAKER FELIX | Director | 04/23/2014 | 3,645,600 |
| Quinn Anthony | EVP, CMO & Head of R&D | 04/01/2014 | 9,500 |
| Quinn Anthony | EVP, CMO & Head of R&D | 04/01/2014 | 239,500 |
| Quinn Anthony | EVP, CMO & Head of R&D | 04/01/2014 | 1,670,691 |
| Heberlig Chris | Group Vice President, Finance | 03/12/2014 | 118,924 |
| Heberlig Chris | Group Vice President, Finance | 03/12/2014 | 755,992 |
| BAKER JULIAN | Director | 03/06/2014 | 39,656,250 |
| BAKER FELIX | Director | 03/06/2014 | 39,656,250 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 02/18/2014 | 16,876 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 02/18/2014 | 1,012,369 |
| Patel Sanj K | President & CEO | 01/28/2014 | 127,874 |
| Patel Sanj K | President & CEO | 01/29/2014 | 179,418 |
| Patel Sanj K | President & CEO | 01/29/2014 | 4,483,953 |
| Patel Sanj K | President & CEO | 01/28/2014 | 4,531,045 |
| Quinn Anthony | EVP, CMO & Head of R&D | 12/31/2013 | 6,970 |
| Williams Glen | SVP, Technical Operations | 12/31/2013 | 4,792 |
| Goldberg Mark Alan | EVP, Medical & Reg. Strategy | 12/31/2013 | 6,970 |
| Heberlig Chris | Group Vice President, Finance | 12/31/2013 | 6,970 |
| Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | 12/02/2013 | 61,110 |
| Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | 12/03/2013 | 423,649 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 11/18/2013 | 16,876 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 11/18/2013 | 546,857 |
| Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | 11/01/2013 | 61,110 |
| Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | 11/01/2013 | 349,753 |
| Goldberg Mark Alan | 10/01/2013 | 61,110 | |
| Goldberg Mark Alan | 10/01/2013 | 450,203 | |
| BAKER FELIX | Director | 09/25/2013 | 59,461,501 |
| BAKER JULIAN | Director | 09/25/2013 | 59,461,501 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 08/21/2013 | 153,663 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 08/20/2013 | 59,545 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 08/20/2013 | 366,912 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 08/21/2013 | 315,276 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 08/16/2013 | 7,310 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 08/16/2013 | 204,121 |
| Patel Sanj K | President & CEO | 07/26/2013 | 152,984 |
| Patel Sanj K | President & CEO | 07/25/2013 | 45,319 |
| Patel Sanj K | President & CEO | 07/29/2013 | 55,950 |
| Patel Sanj K | President & CEO | 07/26/2013 | 3,331,548 |
| Patel Sanj K | President & CEO | 07/25/2013 | 716,867 |
| Patel Sanj K | President & CEO | 07/29/2013 | 753,264 |
| Heberlig Chris | Vice President, Finance | 07/15/2013 | 2,698 |
| Heberlig Chris | Vice President, Finance | 07/16/2013 | 97,920 |
| Heberlig Chris | Vice President, Finance | 07/15/2013 | 24,329 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 07/11/2013 | 22,503 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 07/11/2013 | 622,933 |
| Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | 06/28/2013 | 9,527 |
| Williams Glen | 06/28/2013 | 4,781 | |
| Quinn Anthony | 06/28/2013 | 10,597 | |
| Patel Sanj K | President & CEO | 06/11/2013 | 28,166 |
| Patel Sanj K | President & CEO | 06/12/2013 | 49,383 |
| Patel Sanj K | President & CEO | 06/12/2013 | 1,633,449 |
| Patel Sanj K | President & CEO | 06/11/2013 | 1,212,307 |
| Patel Sanj K | President & CEO | 04/08/2013 | 20,610 |
| Patel Sanj K | President & CEO | 04/05/2013 | 9,414 |
| Patel Sanj K | President & CEO | 04/08/2013 | 1,073,686 |
| Patel Sanj K | President & CEO | 04/05/2013 | 496,590 |
| Patel Sanj K | President & CEO | 04/03/2013 | 15,641 |
| Patel Sanj K | President & CEO | 04/04/2013 | 20,834 |
| Patel Sanj K | President & CEO | 04/03/2013 | 852,227 |
| Patel Sanj K | President & CEO | 04/04/2013 | 1,102,315 |
| Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | 04/01/2013 | 4,195 |
| Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | 04/01/2013 | 239,831 |
| Goldberg Mark Alan | SVP, Product Development | 03/01/2013 | 4,196 |
| Goldberg Mark Alan | SVP, Product Development | 03/01/2013 | 224,217 |
| Patel Sanj K | President & CEO | 02/21/2013 | 43,122 |
| Patel Sanj K | President & CEO | 02/20/2013 | 23,378 |
| Patel Sanj K | President & CEO | 02/21/2013 | 2,225,116 |
| Patel Sanj K | President & CEO | 02/20/2013 | 1,218,505 |
| Goldberg Mark Alan | SVP, Product Development | 02/01/2013 | 4,196 |
| Goldberg Mark Alan | SVP, Product Development | 02/01/2013 | 210,892 |
| Quinn Anthony | SVP, Chief Medical Officer | 01/18/2013 | 8,975 |
| Quinn Anthony | SVP, Chief Medical Officer | 01/18/2013 | 473,106 |
| Quinn Anthony | SVP, Chief Medical Officer | 01/17/2013 | 190 |
| Quinn Anthony | SVP, Chief Medical Officer | 01/16/2013 | 335 |
| Quinn Anthony | SVP, Chief Medical Officer | 01/17/2013 | 10,000 |
| Quinn Anthony | SVP, Chief Medical Officer | 01/16/2013 | 268,025 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 01/16/2013 | 16,876 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 01/16/2013 | 487,614 |
| TISCH THOMAS J | Director | 01/09/2013 | 999,984 |
| BAKER FELIX | Director | 01/04/2013 | 40,862,491 |
| BAKER JULIAN | Director | 01/04/2013 | 40,862,491 |
| Goldberg Mark Alan | SVP, Product Development | 01/02/2013 | 4,196 |
| Goldberg Mark Alan | SVP, Product Development | 01/02/2013 | 209,896 |
| Heberlig Chris | Vice President, Finance | 12/19/2012 | 3,800 |
| Heberlig Chris | Vice President, Finance | 12/19/2012 | 183,705 |
| Patel Sanj K | President & CEO | 12/13/2012 | 13,680 |
| Patel Sanj K | President & CEO | 12/17/2012 | 30,703 |
| Patel Sanj K | President & CEO | 12/14/2012 | 12,617 |
| Patel Sanj K | President & CEO | 12/17/2012 | 1,513,338 |
| Patel Sanj K | President & CEO | 12/14/2012 | 601,629 |
| Patel Sanj K | President & CEO | 12/13/2012 | 657,470 |
| Patel Sanj K | President & CEO | 12/05/2012 | 11,400 |
| Patel Sanj K | President & CEO | 12/04/2012 | 21,850 |
| Patel Sanj K | President & CEO | 12/05/2012 | 577,255 |
| Patel Sanj K | President & CEO | 12/04/2012 | 1,134,850 |
| Patel Sanj K | President & CEO | 12/03/2012 | 28,500 |
| Patel Sanj K | President & CEO | 11/30/2012 | 4,750 |
| Patel Sanj K | President & CEO | 11/30/2012 | 244,326 |
| Patel Sanj K | President & CEO | 12/03/2012 | 1,482,492 |
| Heberlig Chris | Vice President, Finance | 10/17/2012 | 5,300 |
| Heberlig Chris | Vice President, Finance | 10/17/2012 | 198,620 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 10/16/2012 | 16,876 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 10/16/2012 | 497,650 |
| Heberlig Chris | Vice President, Finance | 09/04/2012 | 950 |
| Heberlig Chris | Vice President, Finance | 09/04/2012 | 49,100 |
| Patel Sanj K | President & CEO | 09/04/2012 | 52,072 |
| Patel Sanj K | President & CEO | 08/31/2012 | 14,428 |
| Patel Sanj K | President & CEO | 09/04/2012 | 2,705,372 |
| Patel Sanj K | President & CEO | 08/31/2012 | 757,518 |
| Quinn Anthony | SVP, Chief Medical Officer | 07/27/2012 | 6,080 |
| Quinn Anthony | SVP, Chief Medical Officer | 07/26/2012 | 1,045 |
| Quinn Anthony | SVP, Chief Medical Officer | 07/26/2012 | 55,000 |
| Quinn Anthony | SVP, Chief Medical Officer | 07/27/2012 | 321,501 |
| Quinn Anthony | SVP, Chief Medical Officer | 07/19/2012 | 1,805 |
| Quinn Anthony | SVP, Chief Medical Officer | 07/20/2012 | 570 |
| Quinn Anthony | SVP, Chief Medical Officer | 07/20/2012 | 30,000 |
| Quinn Anthony | SVP, Chief Medical Officer | 07/19/2012 | 95,000 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 07/18/2012 | 11,251 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 07/18/2012 | 323,091 |
| BAKER JULIAN | Director | 07/13/2012 | 36,503,201 |
| BAKER FELIX | Director | 07/13/2012 | 36,503,201 |
| TISCH THOMAS J | Director | 07/12/2012 | 1,503,800 |
| TISCH THOMAS J | Director | 07/12/2012 | 1,503,800 |
| TISCH DANIEL R | 10% Owner | 07/12/2012 | 1,365,100 |
| TISCH DANIEL R | 10% Owner | 07/11/2012 | 457,250 |
| TISCH DANIEL R | 10% Owner | 07/10/2012 | 452,250 |
| AKKARAJU SRINIVAS | Former Director | 06/27/2012 | 12,444,005 |
| AKKARAJU SRINIVAS | Former Director | 06/26/2012 | 1,157,661 |
| Quinn Anthony | SVP, Chief Medical Officer | 06/25/2012 | 1,056,874 |
| Patel Sanj K | President & CEO | 06/04/2012 | 19,823 |
| Patel Sanj K | President & CEO | 06/01/2012 | 27,677 |
| Patel Sanj K | President & CEO | 06/04/2012 | 723,785 |
| Patel Sanj K | President & CEO | 06/01/2012 | 1,042,533 |
| Heberlig Chris | Vice President, Finance | 06/01/2012 | 950 |
| Heberlig Chris | Vice President, Finance | 06/01/2012 | 35,733 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 05/16/2012 | 67,505 |
| BOESS CARSTEN | SVP, Chief Financial Officer | 05/16/2012 | 1,522,933 |
| TISCH DANIEL R | 10% Owner | 04/23/2012 | 120,300 |
| TISCH DANIEL R | 10% Owner | 04/20/2012 | 396,600 |
| Patel Sanj K | 03/23/2012 | 47,500 | |
| Patel Sanj K | 03/23/2012 | 1,676,410 | |
| AKKARAJU SRINIVAS | Director | 03/19/2012 | 11,141,149 |
| TISCH DANIEL R | 10% Owner | 02/29/2012 | 59,255 |
| TISCH DANIEL R | 10% Owner | 02/29/2012 | 136,695 |
| TISCH DANIEL R | 10% Owner | 02/22/2012 | 82,390 |
| TISCH DANIEL R | 10% Owner | 02/06/2012 | 203,604 |
| TISCH DANIEL R | 10% Owner | 02/17/2012 | 353,815 |
| TISCH DANIEL R | 10% Owner | 02/02/2012 | 3,550 |
| TISCH DANIEL R | 10% Owner | 02/16/2012 | 598,657 |
| TISCH DANIEL R | 10% Owner | 02/01/2012 | 354,113 |
| TISCH DANIEL R | 10% Owner | 02/15/2012 | 914,121 |
| TISCH DANIEL R | 10% Owner | 02/13/2012 | 2,217,684 |
| TISCH DANIEL R | 10% Owner | 02/10/2012 | 20,777 |
| TISCH DANIEL R | 10% Owner | 02/07/2012 | 31,382 |
| TISCH DANIEL R | 10% Owner | 02/21/2012 | 36,644 |
| Heberlig Chris | Vice President, Finance | 02/27/2012 | 4,275 |
| Heberlig Chris | Vice President, Finance | 02/27/2012 | 165,960 |
| TISCH THOMAS J | 10% Owner | 01/10/2012 | 3,021,600 |
| TISCH THOMAS J | 10% Owner | 01/10/2012 | 30,216,000 |
| Baker Brothers Life Sciences Capital (GP), LLC | Director | 01/05/2012 | 27,124,526 |
| 14159 capital (GP), LLC | Director | 01/05/2012 | 732,461 |
| Baker Biotech Capital (GP), LLC | Director | 01/05/2012 | 4,723,164 |
| Malley Thomas | Director | 12/12/2011 | 20,887 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 08/19/2011 | 13,266 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 08/18/2011 | 3,165 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 08/04/2011 | 21,800 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 08/03/2011 | 155,100 |
| Baker Brothers Life Sciences Capital (GP), LLC | Director | 09/28/2010 | 34,100 |
| 14159 capital (GP), LLC | Director | 09/28/2010 | 941 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...